WALSH CHRISTOPHER T PHD 4

4 · IRONWOOD PHARMACEUTICALS INC · Filed Feb 11, 2011

Form 4

Period: 2011-02-09

Director

Transactions

Exercise/Conversion
Class B Common Stock
2011-02-09$0.31/sh+6,000$1,860→ 267,026 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2011-02-09−6,000→ 0 total
Exercise: $0.31Exp: 2011-02-12→ Class B Common Stock (6,000 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2010-02-02−6,000→ 0 total
Exercise: $0.10Exp: 2010-05-02→ Class B Common Stock (6,000 underlying)

Footnotes (3)

[F1]The option vested as to 25% of the shares of Class B Common Stock on the three-month anniversary of February 1, 2001 and as to an additional 25% of the original number of shares of Class B Common Stock at the end of each successive full three month period thereafter. The option was fully vested as of February 1, 2002.
[F2]The referenced option was reported in error on the reporting person's Form 3 filed on February 2, 2010. The option was exercised in full prior to the filing date of the Form 3, and the 6,000 shares of Class B Common Stock purchased upon such exercise were already included in the number of shares benefically owned by the reporting person, as reported in Table 1 of Form 3.
[F3]The option vested as to 25% of the shares of Class B Common Stock on each of April 30, 2000, July 31, 2000, October 31, 2000, and January 31, 2001.

Documents

1 file